Literature DB >> 1970369

Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population.

J A Levy1, F Ferro, D Greenspan, E T Lennette.   

Abstract

Human herpesvirus-6 (HHV-6) was recovered at high frequency (greater than 85%) from the saliva of both healthy individuals and those infected with the human immunodeficiency virus (HIV). The level of isolation mirrored the high prevalence of antibodies to HHV-6 found in sera obtained from residents of diverse areas of the world. Seroconversion occurred between 1 and 3 years of age; seroprevalence ranged between 80% and 100% among adults under 40 and decreased to 35% between ages 62 and 88. Serum titres in healthy individuals remained stable during periods of virus shedding. Immune cellular dysfunction in patients was associated with high geometric mean HHV-6 antibody titres. These observations suggest that HHV-6 infection takes place within the first 3 years of life, and strongly implicate oral shedding as a common means of transmission of this newly described herpesvirus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1970369     DOI: 10.1016/0140-6736(90)92628-u

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  58 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

Review 2.  Herpesvirus infections in organ transplant recipients.

Authors:  Frank J Jenkins; David T Rowe; Charles R Rinaldo
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

3.  Potential screening assay for undetectable viruses on the basis of their capacity to induce alpha interferon production.

Authors:  Barbara Schmidt; Brittany Ashlock; Frank Neipel; Jay A Levy
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

4.  Differentiation between two distinct classes of viruses now classified as human herpesvirus 6.

Authors:  E C Schirmer; L S Wyatt; K Yamanishi; W J Rodriguez; N Frenkel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

5.  Monoclonal antibodies to gp100 inhibit penetration of human herpesvirus 6 and polykaryocyte formation in susceptible cells.

Authors:  L Foà-Tomasi; A Boscaro; S di Gaeta; G Campadelli-Fiume
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

6.  Pneumonitis associated with coinfection by human herpesvirus 6 and Legionella in an immunocompetent adult.

Authors:  S K Russler; M A Tapper; K K Knox; A Liepins; D R Carrigan
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

7.  Studies on the antibodies to human herpesvirus type 6 among Hungarian patients with asymptomatic HIV infection.

Authors:  C L Maródi; A Csiszár; B Sierra-Vazquez; D Di Luca; E Barabás; K Nagy; J Ongrádi
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

Review 8.  Human herpesvirus-6 infections.

Authors:  C A Jones; D Isaacs
Journal:  Arch Dis Child       Date:  1996-02       Impact factor: 3.791

9.  Seroepidemiological correlations of antibodies to human herpesviruses and human immunodeficiency virus type 1 in African patients.

Authors:  S Essers; A Schwinn; J ter Meulen; H von Lips; K Dietz; F S Mhalu; J Shao; V ter Meulen
Journal:  Eur J Epidemiol       Date:  1991-11       Impact factor: 8.082

10.  A novel cis element essential for stimulated transcription of the p41 promoter of human herpesvirus 6.

Authors:  J R Thompson; A D Agulnick; R P Ricciardi
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.